Breaking News Instant updates and real-time market news.

BHVN

Biohaven Pharmaceutical

$29.77

1.09 (3.80%)

16:17
05/15/18
05/15
16:17
05/15/18
16:17

Biohaven reports Q1 EPS ($2.32), may not compare to consensus ($1.14)

"In the first quarter of 2018, we continued our strong momentum across our CGRP receptor antagonist and glutamate modulator pipeline programs. The team's stellar performance and progress position us to expect a number of important data announcements and regulatory filings in 2018 and 2019," said Vlad Coric, M.D., CEO of Biohaven. "In our CGRP receptor antagonist platform, we announced positive data from both of our pivotal Phase 3 trials with rimegepant as an acute treatment for migraine, continued our long-term safety study of rimegepant and commenced a clinical trial of our Zydis(R) orally dissolving tablet formulation. We also progressed BHV-3500 toward the clinic for the acute treatment and prevention of migraine. And in our glutamate modulator programs, we continued to progress all three of our drug candidates across multiple indications. Ongoing studies continue with trigriluzole in spinocerebellar ataxia and OCD, while the Alzheimer's disease trial will begin in the second quarter of 2018. We were excited to initiate our expanded access program for sublingual BHV-0223 in ALS and remain on target to submit our NDA in the second half of 2018. Lastly, our oral, low-trapping NMDA antagonist, BHV-5000, is completing nonclinical and Phase 1 work to support later stage development. Our world-class team of clinical and commercial professionals remain dedicated and focused on achieving important milestones over the course of the year."

  • 12

    Jun

BHVN Biohaven Pharmaceutical
$29.77

1.09 (3.80%)

03/27/18
ADAM
03/27/18
NO CHANGE
Target $34
ADAM
Buy
Biohaven Pharmaceutical price target lowered to $34 from $39 at Canaccord
Canaccord analyst Sumant Kulkarni lowered his price target on Biohaven Pharmaceuticals to $34 from $39 following a Phase 3 readout on its acute migraine drug candidate. The analyst raised his probability of approval assumption, but he lowered his free cash flow based price target while noting his model excludes any value for BHV-3500, its additional migraine drug candidate. Kulkarni reiterated his Buy rating on Biohaven shares.
04/05/18
LEHM
04/05/18
DOWNGRADE
Target $25
LEHM
Equal Weight
Biohaven downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Geoffrey Meacham downgraded Biohaven Pharmaceutical to Equal Weight and lowered his price target for the shares to $25 from $30. The analyst believes competitor data in migraine will limit the near-term upside in the shares.
04/05/18
LEHM
04/05/18
NO CHANGE
LEHM
Barclays upgrades Merck, downgrades Biogen and Pfizer in sector reassessment
Barclays analyst Geoff Meacham made some rating changes while reassessing the Biopharmaceutical sector. Biopharma sentiment has been negative since the start of 2018, despite a modest pick-up in deals and diminished rhetoric on drug pricing, Meacham tells investors in a research note titled "U.S. Biopharmaceuticals: Where to from here?" The analyst believes "more transformative" acquisitions, "clean" Phase 3 wins, and even a relatively strong Q1 earnings season could help "re-rate the sector" and get investors more engaged in the group. Ahead of the Q1 earnings season, Meacham upgraded Merck (MRK) to Overweight from Equal Weight and downgraded to Equal Weight from Overweight shares of Biogen (BIIB), Pfizer (PFE), Biohaven Pharmaceutical (BHVN) and Myovant Sciences (MYOV). The analyst also lowered his price target for Equal Weight-rated AbbVie (ABBV) to $102 from $120, for Equal Weight-rated Amgen (AMGN) to $180 from $180, for Overweight-rated Prothena (PRTA) to $50 from $70 and for Overweight-rated Incyte (INCY) to $135 from $165.
04/05/18
04/05/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Hold from Buy at Stifel with analyst Kevin Cassidy citing the peaking server central processing unit cycle and valuation for the downgrade. 2. Johnson Controls (JCI) downgraded to Underperform from Sector Perform at RBC Capital with analyst Deane Dray citing the company's exposure to additional cash flow pressures in fiscal 2018, reduction in fiscal 2020 targets, and a market rotation toward "more defensive names." 3. Ryder (R) downgraded to Underweight from Neutral at JPMorgan with analyst Brian Ossenbeck saying he is making a "longer term call on 2019 expectations," which he believes are too high and embed "significant gains on residual values and used truck sales." 4. Ollie's Bargain Outlet (OLLI) downgraded to Neutral from Buy at BofA/Merrill with analyst Elizabeth Suzuki saying valuation is getting "richer," quarterly comps have been decelerating since 2015, and are now expected to be 1%-2% in 2018. 5. Biogen (BIIB), Pfizer (PFE), Biohaven (BHVN), and Myovant Sciences (MYOV) were downgraded to Equal Weight from Overweight at Barclays. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

DAL

Delta Air Lines

$56.99

0.18 (0.32%)

, EADSY

Airbus

$0.00

(0.00%)

12:42
11/14/18
11/14
12:42
11/14/18
12:42
Periodicals
Delta probable buyer of 10 A330neo aircraft, Reuters says »

Delta (DAL) has emerged…

DAL

Delta Air Lines

$56.99

0.18 (0.32%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CAG

Conagra Brands

$32.82

-2.37 (-6.73%)

12:42
11/14/18
11/14
12:42
11/14/18
12:42
Recommendations
Conagra Brands analyst commentary  »

Conagra increasingly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANY

Sphere 3D

$3.09

1.4 (82.84%)

12:41
11/14/18
11/14
12:41
11/14/18
12:41
Hot Stocks
Sphere 3D spikes after completing Overland Storage divesture »

Shares of Sphere 3D…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FVE

Five Star Senior Living

$0.44

-0.2139 (-32.91%)

12:41
11/14/18
11/14
12:41
11/14/18
12:41
Downgrade
Five Star Senior Living rating change  »

Five Star downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

TSLA

Tesla

$340.60

1.89 (0.56%)

12:38
11/14/18
11/14
12:38
11/14/18
12:38
Periodicals
Citron's Left says he is lead plaintiff in Tesla class action, long the stock »

Citron Research's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 19

    Nov

  • 19

    Nov

  • 13

    Dec

PCG

PG&E

$22.90

-9.8 (-29.97%)

12:30
11/14/18
11/14
12:30
11/14/18
12:30
Technical Analysis
Technical Take: PG&E bounces off lows »

The stock hit an intraday…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTSH

Cognizant

$67.96

-1.63 (-2.34%)

12:25
11/14/18
11/14
12:25
11/14/18
12:25
Options
Cognizant call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 26

    Nov

  • 02

    Dec

SNAP

Snap

$6.53

-0.19 (-2.83%)

12:25
11/14/18
11/14
12:25
11/14/18
12:25
Hot Stocks
Citron's Left discusses Snap long thesis on CNBC »

Citron Research's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 28

    Nov

QRTEA

Qurate Retail

$23.68

-0.2 (-0.84%)

12:25
11/14/18
11/14
12:25
11/14/18
12:25
Conference/Events
Qurate Retail to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

KEYS

Keysight Technologies

$57.85

-0.01 (-0.02%)

, CHL

China Mobile

$47.99

0.37 (0.78%)

12:22
11/14/18
11/14
12:22
11/14/18
12:22
Hot Stocks
Keysight Technologies reports winning bid for 5G test solutions for China Mobile »

Keysight Technologies…

KEYS

Keysight Technologies

$57.85

-0.01 (-0.02%)

CHL

China Mobile

$47.99

0.37 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

MDLZ

Mondelez

$43.79

-0.3 (-0.68%)

12:21
11/14/18
11/14
12:21
11/14/18
12:21
Hot Stocks
Breaking Hot Stocks news story on Mondelez »

Bill Ackman says Pershing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLSN

Nielsen

$26.10

-0.44 (-1.66%)

, DNB

Dun & Bradstreet

$141.94

0.13 (0.09%)

12:21
11/14/18
11/14
12:21
11/14/18
12:21
Hot Stocks
Paulson enters Nielsen, Dun & Bradstreet during Q3, exits CenturyLink »

John Paulson's…

NLSN

Nielsen

$26.10

-0.44 (-1.66%)

DNB

Dun & Bradstreet

$141.94

0.13 (0.09%)

P

Pandora

$8.90

0.18 (2.06%)

CME

CME Group

$187.69

0.31 (0.17%)

BSIG

BrightSphere

$12.89

0.06 (0.47%)

VST

Vistra Energy

$23.79

-0.53 (-2.18%)

EGN

Energen

$70.12

1 (1.45%)

CTL

CenturyLink

$18.87

0.09 (0.48%)

CMCSA

Comcast

$38.08

0.36 (0.95%)

HAIN

Hain Celestial

$22.24

0.16 (0.72%)

DISCA

Discovery

$32.15

0.04 (0.12%)

SHPG

Shire

$180.74

-0.29 (-0.16%)

AET

Aetna

$209.96

0.28 (0.13%)

GOLD

Randgold

$78.96

1.01 (1.30%)

NXPI

NXP Semiconductors

$82.41

0.63 (0.77%)

TMUS

T-Mobile

$68.03

-0.42 (-0.61%)

AKRX

Akorn

$6.74

-0.07 (-1.03%)

MITL

Mitel

$10.98

(0.00%)

MNK

Mallinckrodt

$31.04

-0.045 (-0.14%)

AGN

Allergan

$160.11

-2.525 (-1.55%)

BHC

Bausch Health

$26.89

0.24 (0.90%)

GLD

SPDR Gold Shares

$113.82

0.14 (0.12%)

MYL

Mylan

$34.60

-1.16 (-3.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 16

    Nov

  • 19

    Nov

  • 26

    Nov

  • 27

    Nov

  • 29

    Nov

  • 21

    Dec

  • 15

    Feb

  • 25

    Feb

AAPL

Apple

$188.50

-3.73 (-1.94%)

12:17
11/14/18
11/14
12:17
11/14/18
12:17
Technical Analysis
Technical Take: Apple downside momentum picking up pace »

The stock was last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CSCO

Cisco

$45.01

-0.12 (-0.27%)

12:17
11/14/18
11/14
12:17
11/14/18
12:17
Earnings
Fly Intel: What to watch for in Cisco's earnings report »

Cisco (CSCO) is scheduled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 26

    Nov

  • 10

    Jan

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/14/18
11/14
12:17
11/14/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:16
11/14/18
11/14
12:16
11/14/18
12:16
Conference/Events
UBS MLPs & Natural Gas Analyst to hold a group dinner »

MLPs & Natural Gas…

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/14/18
11/14
12:16
11/14/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNDM

TNDM

12:15
11/14/18
11/14
12:15
11/14/18
12:15
Options
Tandem Diabetes put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 27

    Nov

FB

Facebook

$142.43

0.24 (0.17%)

12:14
11/14/18
11/14
12:14
11/14/18
12:14
Hot Stocks
Citron's Left discussing Facebook long thesis on CNBC »

Andrew Left of Citron…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

IEA

Infrastructure and Energy Alternatives

$8.93

0.45 (5.31%)

12:11
11/14/18
11/14
12:11
11/14/18
12:11
Conference/Events
Infrastructure and Energy Alternatives management to meet with Raymond James »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Dec

VST

Vistra Energy

$23.86

-0.46 (-1.89%)

, EGN

Energen

$70.25

1.13 (1.63%)

12:11
11/14/18
11/14
12:11
11/14/18
12:11
Hot Stocks
Breaking Hot Stocks news story on Vistra Energy, Energen, CenturyLink »

Paulson & Co. exits…

VST

Vistra Energy

$23.86

-0.46 (-1.89%)

EGN

Energen

$70.25

1.13 (1.63%)

CTL

CenturyLink

$18.80

0.02 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVMT

Dell Technologies

$101.23

-0.39 (-0.38%)

12:10
11/14/18
11/14
12:10
11/14/18
12:10
Periodicals
Breaking Periodicals news story on Dell Technologies »

Dell to boost cash…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

KMPR

Kemper

$74.04

-1.31 (-1.74%)

12:10
11/14/18
11/14
12:10
11/14/18
12:10
Conference/Events
Kemper management to meet with Raymond James »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 03

    Dec

  • 04

    Dec

NLSN

Nielsen

$26.04

-0.5 (-1.88%)

, DNB

Dun & Bradstreet

$141.85

0.04 (0.03%)

12:10
11/14/18
11/14
12:10
11/14/18
12:10
Hot Stocks
Breaking Hot Stocks news story on Nielsen, Dun & Bradstreet »

Paulson & Co. takes…

NLSN

Nielsen

$26.04

-0.5 (-1.88%)

DNB

Dun & Bradstreet

$141.85

0.04 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRH

CRH

$29.15

0.2 (0.69%)

12:09
11/14/18
11/14
12:09
11/14/18
12:09
Downgrade
CRH rating change  »

CRH downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.